CRISPR/Cas Technology Could Enable Early Diagnosis of Devastating Citrus Disease
Penn State University and USDA scientists have used cutting-edge CRISPR/Cas technology to develop a diagnostic test that could enable early diagnosis of Huanglongbing or citrus greening, a serious disease that threatens worldwide citrus production, which is valued at roughly $17 billion from the sale of fresh fruit and juices.